News

Truppi in his new role is expected to increase business from US companies based in the Eastern half of North America, mainly focussing on Boston, Pennsylvania and New

Charles River, with the help of the acquisition, will provide research models and associated services for drug discovery and development in China. Charles River Laboratories chairman, president, and

The sale is part of Vion’s revised strategy to disinvest companies that are no longer part of the company’s core activities. Banner Pharmacaps manufactures proprietary softgel capsules for

Under the SC Proven brand, both the companies have launched the first product, ultra-primary human fibroblast cell line, which are believed to be starting material to generate human

The 4-in-1 nutrition shake, which is available in chocolate and vanilla flavors, includes the company’s proprietary Revigor ingredient and 13 grams of protein to help protect, preserve and

Spermatech, an early drug development company, identifies small molecules which can be developed into a non-hormonal male contraceptive. Dotmatics Platform will be used to manage and analyse data

The partnership will focus on developing the small molecule inhibitors as therapeutics to treat cancer in humans. TPP CEO Tom Brown said the agreement will allow the company

The Flanders government has awarded the grant through the agency for innovation by science and technology, IWT. Complix CEO Dr Mark Vaeck said the results generated so far

In addition to the centralized administration, the Web-based quality management system provides scalability to meet PPD’s future growth needs. Sparta Systems product management vice president Michael Jovanis said